| |
|
|
|
Harvard Bioscience  
|
|
4.2201 -0.06 (-0.01%) |
01-21 10:35 |
|
Open: |
4.29 |
Pre close: |
4.28 |
Target:
|
5.15
|
|
High: |
4.32 |
Low: |
4.1619 |
Resistance:
|
4.41
4.65
|
|
Volume: |
18,390 |
Market Cap: |
164M |
Support:
|
4.03
3.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.26
 |
MACD |
MACD(12,26):
|
0.04  |
|
MA(20): |
4.24 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
3.66 |
Stochastic Oscillator |
%K(14,3):
|
36.11 |
|
MA(250): |
3.19 |
%D(3): |
37.55 |
|
Average Volume(K) |
3-Month: |
12766
|
52-Week |
High:
|
4.65 |
|
10-Days: |
12378 |
Low: |
1.39 |
|
RSI |
RSI(14):
|
52.81 |
Change(%): |
41.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.173 |
Return on Equity (ttm) |
-8.6 |
Shares Out. (M) |
38.98 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
0.3 |
Shares Float (M) |
34.66 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.73 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
-12.3 |
% Held by Institutions |
74.91 |
|
Forward EPS |
-0.080 |
Gross Profit (p.s.) |
1.656 |
Shares Short (K) |
584 |
|
Book Value (p.s.) |
1.980 |
EBITDA (p.s.) |
0.218 |
P/E |
-24.57 |
|
Sales Per Share |
2.619 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.15 |
|
Profit Margin |
-6.51 |
Operating Cash Flow
(M) |
9.06 |
P/S |
1.62 |
|
Operating Margin |
0.82 |
Levered Free Cash Flow
(M) |
11.71 |
P/CF |
18.29 |
|
|
|
|
|
|
